Clinical drug trials and tribulations /

Saved in:
Bibliographic Details
Edition:2nd ed., rev. and expanded.
Imprint:New York : Marcel Dekker, c2002.
Description:xiii, 462 p. : ill. ; 24 cm.
Language:English
Series:Drugs and the pharmaceutical sciences ; v. 120
Subject:Drugs -- Testing.
Clinical Trials as Topic.
Pharmaceutical Preparations.
Drugs -- Testing.
Format: Print Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/4754619
Hidden Bibliographic Details
Other authors / contributors:Cato, Allen E., 1939-
Sutton, Lynda, 1956-
Cato, Allen, 1963-
ISBN:0824703146 (alk. paper)
Notes:Includes bibliographical references and index.
LEADER 04647pam a22004814a 4500
001 4754619
003 ICU
005 20031021190300.0
008 020201s2002 nyua b 001 0 eng
010 |a  2002019336 
020 |a 0824703146 (alk. paper) 
035 |a 2002019336 
035 |a (DNLM)101137359 
035 |a (OCoLC)48958509 
040 |a DNLM/DLC  |c DLC  |d NhCcYBP  |d OCoLC  |d OrLoB-B 
042 |a pcc 
050 0 0 |a RM301.27  |b .C5675 2002 
060 1 0 |a W1  |b DR893B v.120 2002 
060 1 0 |a QV 771  |b C6405 2002 
082 0 0 |a 615.5/8/0724  |2 21 
245 0 0 |a Clinical drug trials and tribulations /  |c edited by Allen Cato, Lynda Sutton, Allen Cato III. 
250 |a 2nd ed., rev. and expanded. 
260 |a New York :  |b Marcel Dekker,  |c c2002. 
300 |a xiii, 462 p. :  |b ill. ;  |c 24 cm. 
336 |a text  |b txt  |2 rdacontent  |0 http://id.loc.gov/vocabulary/contentTypes/txt 
337 |a unmediated  |b n  |2 rdamedia  |0 http://id.loc.gov/vocabulary/mediaTypes/n 
338 |a volume  |b nc  |2 rdacarrier  |0 http://id.loc.gov/vocabulary/carriers/nc 
440 0 |a Drugs and the pharmaceutical sciences ;  |v v. 120 
504 |a Includes bibliographical references and index. 
505 0 0 |g 1.  |t Current Challenges and Future Directions of Drug Development /  |r Allen Cato, Lynda Sutton and Allen Cato III --  |g 2.  |t Preclinical Drug Discovery and Development /  |r David S. Duch and Robert M. Ferris --  |g 3.  |t The IND Process for New Drug Products /  |r David M. Cocchetto --  |g 4.  |t Performance and Interpretation of Laboratory Tests /  |r W. Leigh Thompson, Rocco L. Brunelle and Michael G. Wilson --  |g 5.  |t Issues in Endpoint Selection /  |r Karen D. Weiss and Jay Philip Siegel --  |g 6.  |t Dix, Cent, Mille: Proof of Principle with $10 Million, 100 Patients, and 1000 Days /  |r W. Leigh Thompson --  |g 7.  |t Clinical Drug Trials in Pediatrics: Dilemmas of Clinical Drug Trials in Pediatric Populations /  |r Allen Cato and Myron B. Peterson --  |g 8.  |t Electronic Capture of Clinical Trial Information /  |r Daniel C. Cato and David B. Thomas --  |g 9.  |t Providing Patient Access to Promising Investigational Drugs /  |r Peggy J. Berry and Allen Cato --  |g 10.  |t Issues in the Review of Clinical Drug Trials by IRBs /  |r Dale H. Cowan --  |g 11.  |t Personal Care and Randomized Clinical Trials: Understanding the Ethical Conflicts /  |r Paul J. Reitemeier --  |g 12.  |t Informed Consent in Clinical Trials: Emerging Issues /  |r Cheryl K. Fiedler and H. Russell Searight --  |g 13.  |t Orphan Drug Development: David and Goliath /  |r Allen Cato, Susan L. Watts and Lynda Sutton /  |r [et al.] --  |g 14.  |t Single-Event Adverse Drug Reactions: Tribulations in Ascribing Causality /  |r Nelson S. Irey --  |g 15.  |t How to Deal with a Sudden, Unexpected Death in Clinical Studies /  |r Allen Cato and Lynda Sutton --  |g 16.  |t Clinical Trial Material - The Fuel for Clinical Research /  |r David F. Bernstein --  |g 17.  |t The Role of Pharmacokinetics in Drug Development /  |r Allen Cato III and Richard Granneman --  |g 18.  |t Building an NDA/BLA /  |r Diana E. Fordyce and Angela Cahill --  |g 19.  |t International Planning of Drug Clinical Trials /  |r David L. Horwitz --  |g 20.  |t Uncertainty in Drug Development: Approval Success Rates for New Drugs /  |r Joseph A. DiMasi --  |g 21.  |t Contract Clinical Research: Value to In-House Drug Development /  |r F. Richard Nichol --  |g 22.  |t Package Inserts as Viewed by the Busy Private Practitioner /  |r Jean M. Findlay --  |g 23.  |t New Directions in Pharmaceutical Promotion: Regulatory Concerns and Contrivances /  |r Louis A. Morris and Peter H. Rheinstein --  |g 24.  |t The Campus Researcher and Industry: Issues of Intellectual Property and Technology Transfer /  |r Todd S. Keiller --  |g 25.  |t Anatomy of Drug Withdrawals in the United States /  |r Marion J. Finkel --  |g App.  |t Routine Clinical Analyte Test Results. 
650 0 |a Drugs  |x Testing.  |0 http://id.loc.gov/authorities/subjects/sh85039755 
650 1 2 |a Clinical Trials as Topic. 
650 2 2 |a Pharmaceutical Preparations. 
650 7 |a Drugs  |x Testing.  |2 fast  |0 http://id.worldcat.org/fast/fst00898940 
700 1 |a Cato, Allen E.,  |d 1939-  |0 http://id.loc.gov/authorities/names/n88045727  |1 http://viaf.org/viaf/16309106 
700 1 |a Sutton, Lynda,  |d 1956-  |0 http://id.loc.gov/authorities/names/n2002133034  |1 http://viaf.org/viaf/31364964 
700 1 |a Cato, Allen,  |d 1963-  |0 http://id.loc.gov/authorities/names/n2002133035  |1 http://viaf.org/viaf/189481016 
901 |a ToCBNA 
903 |a HeVa 
929 |a cat 
999 f f |i cd684f0e-2962-5dfd-8ea6-94f35d15e36c  |s 4e95f880-03c8-5fbd-a8b5-9e564c23a54c 
928 |t Library of Congress classification  |a RM301.27 .C5675 2002  |l JCL  |c JCL-Sci  |i 6439397 
927 |t Library of Congress classification  |a RM301.27 .C5675 2002  |l JCL  |c JCL-Sci  |e CRERAR  |b 63132069  |i 7358451